Cart
sales@molnova.com
NVP-BDZ 824
CAS No. 916306-04-2
NVP-BDZ 824( NVP-BDZ824 | BDZ 824 )
Catalog No. M16580 CAS No. 916306-04-2
A potent, highly selective antagonist of chemokine receptor CXCR3 with binding IC50 of 146 nM, Ca2+-mobilization IC50 of 28 nM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameNVP-BDZ 824
-
NoteResearch use only, not for human use.
-
Brief DescriptionA potent, highly selective antagonist of chemokine receptor CXCR3 with binding IC50 of 146 nM, Ca2+-mobilization IC50 of 28 nM.
-
DescriptionA potent, highly selective antagonist of chemokine receptor CXCR3 with binding IC50 of 146 nM, Ca2+-mobilization IC50 of 28 nM.
-
In Vitro——
-
In Vivo——
-
SynonymsNVP-BDZ824 | BDZ 824
-
PathwayGPCR/G Protein
-
TargetChemokine Receptor
-
RecptorChemokine Receptor
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number916306-04-2
-
Formula Weight442.563
-
Molecular FormulaC27H30N4O2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical Name(6aR,9R)-N9,N9-diethyl-N7-(o-tolyl)-6,6a,8,9-tetrahydroindolo[4,3-fg]quinoline-7,9(4H)-dicarboxamide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Thoma G, et al. Bioorg Med Chem Lett. 2009 Nov 1;19(21):6185-8.
2. Bernat V, et al. ChemMedChem. 2012 Aug;7(8):1481-9.
molnova catalog
related products
-
MLN3126
MLN3126 (MLN 3126, MLN-3126) is a potent, selective, orally available CCR9 antagonist with IC50 of 6.3 nM (CCL25-induced calcium mobilization).
-
INCB10820
INCB10820 (PF-4178903) is a potent, selective, orally bioavailable dual CCR2 and CCR5 antagonist with binding IC50 of 3.0 nM and 5.3 nM, respectively.
-
CX797
A potent, specfic CXCR2 antagonist that inhibits IL8 down-regulation of forskolin-induced cAMP with IC50 of 7.79 uM.
